The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS.
<h4>Background</h4>Circulating miRNA-34a is increased in blood of patients with different liver diseases when compared to healthy controls. However, the origin of miRNA-34a and its possible relationship with hemodynamics and outcome in cirrhotic patients with portal hypertension is unkno...
Guardado en:
Autores principales: | Christian Jansen, Hannah Eischeid, Jan Goertzen, Robert Schierwagen, Evrim Anadol, Christian P Strassburg, Tilman Sauerbruch, Margarete Odenthal, Jonel Trebicka |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/65ad1435f5e54d9385d8297e8c3ead25 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of circulating angiogenin levels in portal hypertension and TIPS.
por: Alexander Queck, et al.
Publicado: (2021) -
Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension.
por: Jonel Trebicka, et al.
Publicado: (2013) -
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension.
por: Christian Jansen, et al.
Publicado: (2014) -
Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension
por: Gioia S, et al.
Publicado: (2021) -
Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib.
por: Romain Coriat, et al.
Publicado: (2011)